DNDi and Atomwise collaborate to advance drug development using AI for neglected diseases

(JPA Health) Atomwise Inc., a biotech company using artificial intelligence (AI) for drug discovery, and the Drugs for Neglected Diseases initiative (DNDi), a not-for-profit research and development organization working to deliver new treatments for neglected diseases, today announced that promising drug-like compounds have been discovered in a program to develop first-in-class treatments for Chagas disease. The research collaboration is part of Atomwise's Artificial Intelligence Molecular Screen (AIMS) Awards program.
Source: EurekAlert! - Biology - Category: Biology Source Type: news